Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Monthly Communication Reports in the last 6 Months for GlaxoSmithKline Inc.

Sridhar Venkatesh, General Manager and President (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results null-null of 14

  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Salma Zahid, Member of Parliament | House of Commons
    • Jade Mallette, Chief of Staff to the Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Immigration
    Communication date: 2025-11-25
    Posted date: 2025-12-15
    Communication number: 5088-663396 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health, Industry, Economic Development
    Communication date: 2025-11-21
    Posted date: 2025-12-02
    Communication number: 5088-659216 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • jeff kibble, Député | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2025-11-12
    Posted date: 2025-12-02
    Communication number: 5088-659214 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health, Budget, Economic Development
    Communication date: 2025-11-10
    Posted date: 2025-12-02
    Communication number: 5088-659220 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rachael Thomas, Président | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2025-10-10
    Posted date: 2025-10-27
    Communication number: 5088-652463 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Warren Steinley, Député | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2025-10-06
    Posted date: 2025-10-27
    Communication number: 5088-652462 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Philip Jennings, Deputy Minister | Office of the Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Paul Moen, Chief of Staff | Minister's Office | Innovation, Science and Economic Development Canada (ISED)
    • Manuela Tomic, Policy Advisor | Minister's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health, Industry, International Trade, Budget, Economic Development
    Communication date: 2025-09-22
    Posted date: 2025-10-15
    Communication number: 5088-647166 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Salma Zahid, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Immigration
    Communication date: 2025-09-03
    Posted date: 2025-10-15
    Communication number: 5088-644746 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Iqra Khalid, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Immigration
    Communication date: 2025-09-03
    Posted date: 2025-10-15
    Communication number: 5088-644701 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Daniel MacDonald, Director General, Office of Pharmaceutical Management Strategies | Health Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health, International Trade, Economic Development
    Communication date: 2025-07-30
    Posted date: 2025-08-15
    Communication number: 5088-641553 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Manuela Tomic, Policy Advisor | Minister's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, International Trade, Economic Development
    Communication date: 2025-07-30
    Posted date: 2025-08-15
    Communication number: 5088-641543 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ian Foucher, Chief of Staff | Minister's Office | Finance Canada (FIN)

    Subject Matter of the communication: Health, International Trade, Economic Development
    Communication date: 2025-07-30
    Posted date: 2025-08-15
    Communication number: 5088-641525 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Neeraj Bhalla, Director of Stakeholder Relations | Minister's Office | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Immigration, International Trade, Economic Development
    Communication date: 2025-07-29
    Posted date: 2025-08-15
    Communication number: 5088-641412 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dan Mazier, Member of Parliament | House of Commons
    • Kier Doyle, Parliamentary Assistant | House of Commons

    Subject Matter of the communication: Health, International Trade, Economic Development
    Communication date: 2025-07-22
    Posted date: 2025-08-15
    Communication number: 5088-640975 View monthly communication report
Date Modified: